NCT06362369 2026-04-13A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled
NCT06870487 2026-04-01A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled
NCT03420963 2026-03-20Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled